Skip to Content

Mometasone Topical Dosage

Applies to the following strength(s): 0.1%

The information at Drugs.com is not a substitute for medical advice. ALWAYS consult your doctor or pharmacist.

Usual Adult Dose for:

Usual Pediatric Dose for:

Additional dosage information:

Usual Adult Dose for Dermatitis

Apply a thin layer to the affected area once a day

Comments:
-This topical drug should not be used with occlusive dressings unless directed by a healthcare provider.
-Therapy should be discontinued when control is obtained.
-If no improvement is seen within 2 weeks, reassessment of diagnosis may be needed.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Adult Dose for Eczema

Apply a thin layer to the affected area once a day

Comments:
-This topical drug should not be used with occlusive dressings unless directed by a healthcare provider.
-Therapy should be discontinued when control is obtained.
-If no improvement is seen within 2 weeks, reassessment of diagnosis may be needed.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Adult Dose for Psoriasis

Apply a thin layer to the affected area once a day

Comments:
-This topical drug should not be used with occlusive dressings unless directed by a healthcare provider.
-Therapy should be discontinued when control is obtained.
-If no improvement is seen within 2 weeks, reassessment of diagnosis may be needed.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Pediatric Dose for Dermatitis

2 years and older:
Cream/ointment: Apply a thin layer to the affected area once a day

12 years and older:
Lotion: Apply a thin layer to the affected area once a day

Comments:
-Safety and efficacy in pediatric patients for more than 3 weeks of use have not been established.
-This topical drug should not be applied in the diaper area if the child still requires diapers or plastic pants.
-Therapy should be discontinued when control is obtained.
-If no improvement is seen within 2 weeks, reassessment of diagnosis may be needed.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Pediatric Dose for Eczema

2 years and older:
Cream/ointment: Apply a thin layer to the affected area once a day

12 years and older:
Lotion: Apply a thin layer to the affected area once a day

Comments:
-Safety and efficacy in pediatric patients for more than 3 weeks of use have not been established.
-This topical drug should not be applied in the diaper area if the child still requires diapers or plastic pants.
-Therapy should be discontinued when control is obtained.
-If no improvement is seen within 2 weeks, reassessment of diagnosis may be needed.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Pediatric Dose for Psoriasis

2 years and older:
Cream/ointment: Apply a thin layer to the affected area once a day

12 years and older:
Lotion: Apply a thin layer to the affected area once a day

Comments:
-Safety and efficacy in pediatric patients for more than 3 weeks of use have not been established.
-This topical drug should not be applied in the diaper area if the child still requires diapers or plastic pants.
-Therapy should be discontinued when control is obtained.
-If no improvement is seen within 2 weeks, reassessment of diagnosis may be needed.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

Safety and efficacy have not been established in patients younger than 2 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:
-The treated area should not be bandaged, covered, or wrapped, as to be occlusive, unless directed by a healthcare provider.
-Parents of pediatric patients should be advised not to use tight-fitting diapers or plastic pants on a child being treated in the diaper area.

Monitoring:
-Endocrine: HPA-axis suppression (Urinary free-cortisol test, ACTH-stimulation test)

Patient advice:
-Use should be avoided on the face, groin, or axillae.
-Patients should report any signs of local adverse reactions, especially those that develop under occlusive dressings.
-This medication is to be used as directed by the physician.
-Patients should be advised not to use this medication for any condition other than for which it was prescribed.
-Lotion should not be used in the treatment of diaper dermatitis.

Hide